BACKGROUND: Nipple-sparing mastectomy (NSM) is reserved for patients who meet specific criteria to optimize considerations in the oncologic domain and reduce complications. 1 Trend toward the development of more broader reconstructive indications for NSM is directly related to patient demand and the possibility to achieve a better esthetic outcomes. 2 Several studies have demonstrated the safety of this procedure in patients with increased risk factors. 3, 4 Well-selected high-risk patients can safely undergo NSM and implant reconstruction in 1 stage or 2 stages.
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PURPOSE:
To compare risk factors and complications in patients after NSM and implant-based breast reconstruction.
METHODS:
A retrospective chart review was performed in a tertiary institution from 2016 to 2018. All patients who underwent NSM followed by 2-stage or direct-to-implant (DTI) reconstruction had their information collected per reconstructed breast. Patient demographics, previous surgeries, smoking status, radiotherapy history, surgical information, and postoperative complications (delayed wound healing, dehiscence, mastectomy flap necrosis, and infection) were collected.
RESULTS:
A total of 217 breasts were analyzed: 110 (50.69%) underwent DTI and 107 (49.30%) 2-stage reconstructions. DTI group had patients with slightly older age (48.88 ± 12.78 versus 45.31 ± 10.8; P = 0.02), higher body mass index (27.35 ± 5.97 versus 24.89 ± 4.95; P = 0.001), higher mastectomy weight (455.62 ± 229.05 g versus 372.213 ± 213.06 g; P = 0.006), and higher ptosis grades (P = 0.010). The groups were similar for smoking status, history of radiation, and prophylactic mastectomy. DTI group had more prepectoral reconstructions than TE group (65 [59.09%] versus 22 [20.56%]) and used acellular dermal grafts more frequently (110 [100%] versus 83 [77.6%]) (P < 0.001). There were no significant differences in complication rates between the groups (28.97% versus 33.63%; P = 0.47) and reoperation rates (12.14% versus 15.45%; P = 0.56).
Number of revision surgery was similar between both groups (P = 0.17). The number of surgeries required on the entire reconstruction process was bigger on the 2 stages group 2.48 ± 1 versus 1.4 ± 0.75 (P < 0.001). Successful implant-based reconstructions were achieved in 90.81% on TE group and 96.36% on DTI group (P = 0.121).
CONCLUSION:
Implant-based breast reconstruction after NSM can be successfully achieved in 1 or 2 stages with similar rates of complication, reoperation, and revision. The patients who underwent DTI reconstructions had similar rates of successful reconstructions despite the higher body mass index, older age, higher mastectomy specimens' weights, and higher preoperative ptosis grades.
